Campregher et al. identified a t(7; 12)(p15; p13) chromosomal translocation that generates an ETV6-ANLN fusion gene, resulting in high expression of the ETV6-ANLN transcript in both myeloid and lymphoid lineages, thereby implicating ANLN in the pathogenesis of hematologic malignancies (Campregher et al., 2015). This evidence concerns the gene ETV6 and hematologic disorder.